SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-25-011169 from Klotho Neurosciences, Inc. (KLTO, KLTOW) (CIK 0001907223) (KLTO)

Klotho Neurosciences, Inc. (KLTO, KLTOW) (CIK 0001907223)
Date: Feb. 7, 2025 · CIK: 0001907223 · Accession: 0001213900-25-011169

Offering / Registration Process Regulatory Compliance Business Model Clarity

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-284602

Date
February 7, 2025
Author
/s/ Joseph Sinkule
Form
CORRESP
Company
Klotho Neurosciences, Inc. (KLTO, KLTOW) (CIK 0001907223)

Letter

RE: Klotho Neurosciences, Inc.

KLOTHO NEUROSCIENCES, INC.

February 7, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Registration Statement on Form S-1, filed January 30, 2025

(File No. 333-284602) (the “Registration Statement”)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, Klotho Neurosciences, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30 p.m. ET on Monday, February 10, 2025, or as soon thereafter as is practicable, unless we or our outside counsel, Paul Goodman request by telephone that such Registration Statement be declared effective at some other time.

Please direct any questions regarding this filing to Paul Goodman, Esq at 917-596-0905.

Very truly yours,
By:
/s/ Joseph Sinkule

Show Raw Text
CORRESP
1
filename1.htm

KLOTHO NEUROSCIENCES, INC.

February 7, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

    RE:
    Klotho Neurosciences, Inc.

    Registration Statement on Form S-1, filed January 30, 2025

    (File No. 333-284602) (the “Registration Statement”)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act
of 1933, as amended, Klotho Neurosciences, Inc. (the “Company”) hereby respectfully requests that the effective date of the
above-referenced Registration Statement be accelerated so that the same will become effective at 4:30 p.m. ET on Monday, February 10,
2025, or as soon thereafter as is practicable, unless we or our outside counsel, Paul Goodman request by telephone that such Registration
Statement be declared effective at some other time.

Please direct any questions regarding this filing to
Paul Goodman, Esq at 917-596-0905.

    Very truly yours,

    By:
    /s/ Joseph Sinkule

    Name:
    Joseph Sinkule

    Title:
    Chief Executive Officer